Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-22
2008-07-22
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
10561844
ABSTRACT:
The present invention relates to S-tenatoprazole monohydrated sodium salt, represented by the following formulaand the use thereof in therapy for the treatment of digestive diseases.
REFERENCES:
patent: 5753265 (1998-05-01), Bergstrand et al.
patent: 7034038 (2006-04-01), Cohen et al.
patent: 2006/0194832 (2006-08-01), Cohen et al.
patent: 2006/0241136 (2006-10-01), Schutze et al.
patent: 2006/0287284 (2006-12-01), Schutze et al.
patent: 2007/0066659 (2007-03-01), Schutze et al.
patent: 1453278 (2003-11-01), None
patent: 0 254 588 (1988-01-01), None
patent: 2 848 555 (2004-06-01), None
patent: 2004/074285 (2004-09-01), None
Bunpei Kakinoki et al. “General Pharmacological Properties of the New Proton Pump Inhibitor (±)-5-Methoxy-2-[[(4-methoxy-3, 5-dimethylpyrid-2-yl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine”, vol. 21, No. 3, 1999, pp. 179-187.
International Search Reported dated Nov. 30, 2005.
Charbit Suzy
Cohen Avraham
Ficheux Hervé
Homerin Michel
Martinet Frédéric
Crowell & Moring LLP
Rahmani Niloofar
Seaman D. Margaret
Sidem Pharma
LandOfFree
Monohydrated sodium salt of S-tenatoprazole and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monohydrated sodium salt of S-tenatoprazole and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monohydrated sodium salt of S-tenatoprazole and the use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3920994